Zoetis (ZTS)
152.12
-0.70 (-0.46%)
NYSE · Last Trade: Jul 26th, 8:55 AM EDT
The "Warren Buffett of Britain" dumped Buffett's actual No. 1 holding in favor a stock with the legs to run higher.
Via The Motley Fool · July 25, 2025
Over the last six months, Zoetis’s shares have sunk to $153.39, producing a disappointing 11.4% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have investors wondering how to approach the situation.
Via StockStory · July 25, 2025
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers.
Via StockStory · July 23, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best and worst performers in the branded pharmaceuticals industry.
Via StockStory · July 23, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Via StockStory · July 17, 2025
Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
Via Benzinga · July 7, 2025
Via The Motley Fool · July 7, 2025
By avoiding big swings, low-volatility stocks let investors focus on long-term fundamentals.
These stocks may not be up 100% in a single year, but they offer a measured approach to building wealth over time.
Via StockStory · July 4, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · July 2, 2025
Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval.
Via Benzinga · June 26, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · June 23, 2025
Via Benzinga · June 18, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · June 18, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · June 18, 2025
Via Benzinga · June 18, 2025
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · June 18, 2025
Via Benzinga · June 12, 2025
Steady growth and dividend increases over decades can make investors remarkably wealthy.
Via The Motley Fool · June 11, 2025

The business may be somewhat boring, but it consistently delivers year after year, resulting in tremendous long-term returns.
Via The Motley Fool · June 1, 2025